INDIA |NSE |INR
Shares Outstanding | 12.22M | Beta | 1.78 |
---|---|---|---|
Public Float | 4.20M | P/E Ratio | 51.17 |
% Short of Float | - | Dividend (Yield) | - |
Held by Insiders | 62.10% | Ex-Dividend Date | |
Held by Institutions | - | IPO Date | - |
Mar 21 | Mar 20 | Mar 19 | |
---|---|---|---|
Revenue | INR1.13B | INR1.26B | INR1.23B |
EBITDA | INR199.78M | INR210.48M | INR206.74M |
Net Income | INR121.29M | INR132.91M | INR120.26M |
Total Assets | INR1.94B | INR1.81B | INR1.37B |
Total Cash | INR16.57M | INR17.10M | INR73.50M |
Total Debt | INR | INR | INR |
Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|
Revenue | INR326.41M | INR325.20M | INR275.30M |
EBITDA | INR71.36M | INR67.03M | INR61.20M |
Net Income | INR37.78M | INR42.22M | INR41.51M |
Total Assets | INR | INR2.03B | INR |
Total Cash | INR | INR37.56M | INR |
Total Debt | INR | INR | INR |
Date | Open | High | Low | Close | Change | Volume |
---|---|---|---|---|---|---|
Jun 9, 2022 | INR667.00 | INR691.00 | INR651.60 | INR661.20 | 15.17% | 4.80K |
Jun 22, 2022 | INR569.05 | INR598.00 | INR563.05 | INR574.10 | -9.17% | 10.75K |
Jun 13, 2022 | INR650.20 | INR650.20 | INR625.00 | INR632.05 | -8.89% | 9.93K |
Medicamen biotech trades on the NSE stock market in India under the ticker symbol "MEDICAMEQ". Medicamen biotech’s stock symbol can also be displayed as "NSE:MEDICAMEQ".
Medicamen biotech (NSE:MEDICAMEQ) is owned by 0.00% institutional shareholders and by 62.10% insiders. The rest is owned by the public.
Explore More Details on Medicamen biotech's “Ownership” Section
Medicamen biotech's key executive team includes the following managers:
Medicamen biotech (NSE:MEDICAMEQ) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.
Currently the number of employees working for Medicamen biotech is 289.
Medicamen biotech (NSE:MEDICAMEQ) is headquartered in India.
Medicamen biotech’s mailing address is 1506, Chiranjiv Tower, New Delhi, India, 110019.
The company’s phone number is 91 11 4758 9500.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.